ScholarIQanswers from OpenAlex & ORCID
Michel D. Ferrari
ResearcherPublications, citations & collaboration network
Michel D. Ferrari is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michel D. Ferrari have?
ScholarIQindexed works
Michel D. Ferrari has 763 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michel D. Ferrari have?
ScholarIQcitation count
Michel D. Ferrari has 49,458 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michel D. Ferrari?
ScholarIQh-index
Michel D. Ferrari has an h-index of 106 in OpenAlex.
What is the i10-index of Michel D. Ferrari?
ScholarIQi10-index
Michel D. Ferrari has an i10-index of 461 in OpenAlex.
What is the ORCID of Michel D. Ferrari?
ScholarIQorcid
The ORCID for Michel D. Ferrari is on the source record.
What is the OpenAlex record for Michel D. Ferrari?
ScholarIQopenalex
The OpenAlex for Michel D. Ferrari is on the source record.
What are the most-cited papers on Michel D. Ferrari?
ScholarIQmost cited works
Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4
Roel A. Ophoff, Gisela M. Terwindt, Monique N. Vergouwe, Ronald van Eijk, Peter J. Oefner, Susan M.G. Hoffman, Jane E. Lamerdin, Harvey W. Mohrenweiser, Dennis E. Bulman, Maurizio Ferrari, Joost Haan, Dick Lindhout, Gert‐Jan B. van Ommen, Marten H. Hofker, Michel D. Ferrari, Rune R. Frants
Migraine — Current Understanding and Treatment
Peter J. Goadsby, Richard B. Lipton, Michel D. Ferrari
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials
Michel D. Ferrari, Krista I Roon, Richard B. Lipton, Peter J. Goadsby
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho, Michel D. Ferrari, David W. Dodick, Vince Galet, James Kost, Xiaoyin Fan, Heather Leibensperger, Samar Froman, Christopher Assaid, Christopher Lines, Hille Koppen, Paul Winner
C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy
Anna Richards, Arn M. J. M. van den Maagdenberg, Joanna C. Jen, David Kavanagh, Paula Bertram, Dirk Spitzer, M. Kathryn Liszewski, Maria Louise Barilla-Labarca, Gisela M. Terwindt, Yumi Kasai, Mike McLellan, M. Gilbert Grand, Kaate R. J. Vanmolkot, Boukje de Vries, Jijun Wan, Michael J. Kane, Hafsa Mamsa, R Schäfer, Anine H Stam, Joost Haan, Paulus T.V.M. de Jong, Caroline W. J. M. Storimans, Mary J. van Schooneveld, J.A. Oosterhuis, Andreas Gschwendter, Martin Dichgans, Katya Kotschet, Suzanne Hodgkinson, Todd A. Hardy, Martin B. Delatycki, Rula A. Hajj‐Ali, Parul H. Kothari, Stanley F. Nelson, Rune R. Frants, Robert W. Baloh, Michel D. Ferrari, John P. Atkinson